These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

235 related articles for article (PubMed ID: 26314580)

  • 21. Fasciola hepatica: Histology of the testis in egg-producing adults of several laboratory-maintained isolates of flukes grown to maturity in cattle and sheep and in flukes from naturally infected hosts.
    Hanna RE; Edgar H; Moffett D; McConnell S; Fairweather I; Brennan GP; Trudgett A; Hoey EM; Cromie L; Taylor SM; Daniel R
    Vet Parasitol; 2008 Nov; 157(3-4):222-34. PubMed ID: 18774647
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparing an in vivo egg reduction test and in vitro egg hatching assay for different anthelmintics against Fasciola species, in cattle.
    Arafa WM; Shokeir KM; Khateib AM
    Vet Parasitol; 2015 Nov; 214(1-2):152-8. PubMed ID: 26455573
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased susceptibility of a triclabendazole (TCBZ)-resistant isolate of Fasciola hepatica to TCBZ following co-incubation in vitro with the P-glycoprotein inhibitor, R(+)-verapamil.
    Meaney M; Savage J; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Parasitology; 2013 Sep; 140(10):1287-303. PubMed ID: 23756576
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy of nitroxynil against Fasciola hepatica resistant to triclabendazole in a naturally infected sheep flock.
    Martínez-Valladares M; del Rosario Famularo M; Fernández-Pato N; Castañón-Ordóñez L; Cordero-Pérez C; Rojo-Vázquez FA
    Parasitol Res; 2010 Oct; 107(5):1205-11. PubMed ID: 20680341
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Unchanged triclabendazole kinetics after co-administration with ivermectin and methimazole: failure of its therapeutic activity against triclabendazole-resistant liver flukes.
    Ceballos L; Moreno L; Alvarez L; Shaw L; Fairweather I; Lanusse C
    BMC Vet Res; 2010 Feb; 6():8. PubMed ID: 20128898
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The diagnosis of fasciolosis in feces of sheep by means of a PCR and its application in the detection of anthelmintic resistance in sheep flocks naturally infected.
    Robles-Pérez D; Martínez-Pérez JM; Rojo-Vázquez FA; Martínez-Valladares M
    Vet Parasitol; 2013 Oct; 197(1-2):277-82. PubMed ID: 23743420
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fasciola hepatica: histological demonstration of apoptosis in the reproductive organs of flukes of triclabendazole-sensitive and triclabendazole-resistant isolates, and in field-derived flukes from triclabendazole-treated hosts, using in situ hybridisation to visualise endonuclease-generated DNA strand breaks.
    Hanna RE; Forster FI; Brennan GP; Fairweather I
    Vet Parasitol; 2013 Jan; 191(3-4):240-51. PubMed ID: 23062689
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increase of carboxylesterase activity in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Miranda-Miranda E; Cossío-Bayúgar R; Ceballos L; Fernandez V; Solana H
    Mol Biochem Parasitol; 2012 Oct; 185(2):151-3. PubMed ID: 22814337
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of an anthelmintic combination in sheep infected with Fasciola hepatica resistant to albendazole and clorsulon.
    Martínez-Valladares M; Cordero-Pérez C; Rojo-Vázquez FA
    Exp Parasitol; 2014 Jan; 136():59-62. PubMed ID: 24211419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Resistance-induced changes in triclabendazole transport in Fasciola hepatica: ivermectin reversal effect.
    Mottier L; Alvarez L; Fairweather I; Lanusse C
    J Parasitol; 2006 Dec; 92(6):1355-60. PubMed ID: 17304820
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Resistance of Fasciola hepatica against triclabendazole in cattle and sheep in The netherlands.
    Moll L; Gaasenbeek CP; Vellema P; Borgsteede FH
    Vet Parasitol; 2000 Jul; 91(1-2):153-8. PubMed ID: 10889368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Increase of gluthatione S-transferase, carboxyl esterase and carbonyl reductase in Fasciola hepatica recovered from triclabendazole treated sheep.
    Scarcella S; Solana MV; Fernandez V; Lamenza P; Ceballos L; Solana H
    Mol Biochem Parasitol; 2013 Oct; 191(2):63-5. PubMed ID: 24041589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increased action of triclabendazole (TCBZ) in vitro against a TCBZ-resistant isolate of Fasciola hepatica following its co-incubation with the P-glycoprotein inhibitor, R(+)-verapamil.
    Savage J; Meaney M; Brennan GP; Hoey E; Trudgett A; Fairweather I
    Exp Parasitol; 2013 Nov; 135(3):642-53. PubMed ID: 24090567
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Composite faecal egg count reduction test to detect resistance to triclabendazole in Fasciola hepatica.
    Daniel R; van Dijk J; Jenkins T; Akca A; Mearns R; Williams DJ
    Vet Rec; 2012 Aug; 171(6):153, 1-5. PubMed ID: 22791519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Disruption of egg formation by Fasciola hepatica following treatment in vivo with triclabendazole in the sheep host.
    Toner E; Brennan GP; Hanna RE; Edgar HW; Fairweather I
    Vet Parasitol; 2011 Apr; 177(1-2):79-89. PubMed ID: 21163580
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro effects of triclabendazole (TCBZ) on the excretory-secretory products (ESP) of Fasciola spp parasites.
    Farahnak A; Golmohamdi T; Eshraghian M
    Acta Med Iran; 2012; 50(3):164-8. PubMed ID: 22418984
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Tegumental surface changes in juvenile Fasciola hepatica in response to treatment in vivo with triclabendazole.
    Halferty L; Brennan GP; Hanna RE; Edgar HW; Meaney MM; McConville M; Trudgett A; Hoey L; Fairweather I
    Vet Parasitol; 2008 Aug; 155(1-2):49-58. PubMed ID: 18511199
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Intraspecific mitochondrial DNA variation of Fasciola hepatica eggs from sheep with different level of anthelmintic resistance.
    Martínez-Valladares M; Rojo-Vázquez FA
    Parasitol Res; 2014 Jul; 113(7):2733-41. PubMed ID: 24832814
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative assessment of the access of albendazole, fenbendazole and triclabendazole to Fasciola hepatica: effect of bile in the incubation medium.
    Alvarez LI; Mottier ML; Lanusse CE
    Parasitology; 2004 Jan; 128(Pt 1):73-81. PubMed ID: 15002906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potentiation of triclabendazole action in vivo against a triclabendazole-resistant isolate of Fasciola hepatica following its co-administration with the metabolic inhibitor, ketoconazole.
    Devine C; Brennan GP; Lanusse CE; Alvarez LI; Trudgett A; Hoey E; Fairweather I
    Vet Parasitol; 2012 Feb; 184(1):37-47. PubMed ID: 21872399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.